https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=MEDINCELLMEDINCELL - Revizia istoricului2026-04-12T17:26:37ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=MEDINCELL&diff=369533&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei MEDINCELL listata cu simbolul FR.MEDCL ==Descriere companie== Medincell SA (www.medincell.com) is a France-based manufacturer of biological products and pharmaceutical preparations. The Company is focused on the development of therapeutic solutions with worldwide access. The Company works on both for-profit and non-profit projects, in collaboration with partners ranging from pharmaceutical corporations to physicians, from biotechnology firms to acad...2024-09-18T12:39:07Z<p>Pagină nouă: Pagina dedicata companiei MEDINCELL listata cu simbolul FR.MEDCL ==Descriere companie== Medincell SA (www.medincell.com) is a France-based manufacturer of biological products and pharmaceutical preparations. The Company is focused on the development of therapeutic solutions with worldwide access. The Company works on both for-profit and non-profit projects, in collaboration with partners ranging from pharmaceutical corporations to physicians, from biotechnology firms to acad...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei MEDINCELL listata cu simbolul FR.MEDCL<br />
<br />
==Descriere companie==<br />
Medincell SA (www.medincell.com) is a France-based manufacturer of biological products and pharmaceutical preparations. The Company is focused on the development of therapeutic solutions with worldwide access. The Company works on both for-profit and non-profit projects, in collaboration with partners ranging from pharmaceutical corporations to physicians, from biotechnology firms to academics and foundations. Its range of products consists of three products in development phase: mdc-IRM, a subcutaneous injection in phase III clinical study for the treatment of schizophrenia; mdc-CWM, an intra-articular injection in phase II clinical study for the treatment of post-surgical pain and inflammation; mdc-TJK, a subcutaneous injection for the treatment of schizophrenia, as well as a number of other products that are in the research phase, such as mdc-WWM, which is a subcutaneous injection for contraception, and mdc-ELK, a subcutaneous injection for the treatment of depression, among others.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/FR.MEDCL" /><br />
<br />
==Ultimele stiri despre MEDINCELL (FR.MEDCL)==<br />
<dynamicpagelist><br />
category=FR.MEDCL<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:FR.MEDCL]][[Categorie:Stiri despre companii]]</div>Admin